Issue Date: March 26, 2012
Bend Delves Into Biotherapeutics
Bend Research, an Oregon-based drug formulation development firm, is expanding its process engineering capabilities into biotherapeutics production. As part of a long-term collaboration, Bend and Pfizer have been developing bioprocessing tools and models, along with process analytics, to advance Pfizer’s biopharmaceutical and vaccine candidates. The partners are also designing a “plant of the future” that reduces capital investment by one-half and operating costs by two-thirds.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society